SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is under pressure amid a selloff in AI infrastructure stocks, as traders focus on its heavy debt, costly financing needs, and whether its contracted demand can support further growth. Bears fear dilution or default, while dip buyers point to the backlog and Nvidia ties; Goldmans upgrade and ARKs buying have not resolved the debate.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention amid a steep selloff and negative political sentiment surrounding Trump, with traders pointing to his reported record-low approval and approaching midterms as potential headwinds. The discussion is overwhelmingly bearish, though a few traders describe the decline as a speculative buying opportunity.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Ciphers steep selloff and fresh 52-week lows are driving discussion, with traders focused on dilution and financing concerns around its convertible-note offering, alongside broader scrutiny of AI data-center costs. Bearish reactions criticize management and the share overhang, while bulls point to long-term AI infrastructure demand and data-center contracts as reasons for optimism.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 report is the dominant focus, with traders watching for signs that subscriber growth and viewer engagement are holding up, alongside guidance on advertising and margins. The stocks weakness and analyst target cuts have fueled bearish calls for more downside, while some traders see subdued expectations as a setup for a rebound.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Attention is centered on Vicors upcoming quarterly results, with traders pointing to two Q3 growth-guidance increases tied to higher royalties from its Vertical Power Delivery licenses. The community is split between bullish earnings expectations and dip-buying, and concerns about volatility and the stocks history of post-earnings pullbacks.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos steep selloff and an analysts sharp price-target cut are driving discussion, with traders debating whether the decline reflects stretched valuation and resetting growth expectations or broader weakness in defense and drone stocks. Some remain bullish on contract momentum and long-term demand for unmanned systems, while others are frustrated that positive business updates have not steadied the share price.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios FDA label expansion for ANKTIVA to cover papillary-only BCG-unresponsive bladder cancer, alongside favorable long-term bladder data, is driving discussion. The shares sharp decline despite the positive developments has sparked debate over a sell-the-news reaction and broader biotech weakness versus concerns about revenue growth, valuation, and competition; many holders instead blame short selling, though that claim is unverified.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares have fallen sharply to post-IPO lows, with traders pointing to lockup-related share supply, insider selling and a TD Cowen price-target cut as sources of pressure. The conversation is largely bearish over valuation, growth and customer concentration, though some investors see the selloff as an oversold buying opportunity and remain bullish on the companys AI-chip technology.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is drawing attention after a sharp, volatile memory-stock selloff tied to concerns about Chinese competition, the durability of AI-driven demand, and foreign outflows from South Korea; a rebound has renewed dip-buying. Traders disagree on whether the decline is an overreaction to near-term fears or a warning that the memory cycle is normalizing.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanley named Amazon a top pick, citing stronger AWS growth prospects tied to AI demand and Nvidia GPU deployments, prompting a sharp share-price rally. Traders largely welcomed the upgrade, while others questioned whether the gains would hold and pointed to earnings and nearby resistance as tests.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.read more...

Kura Oncology Q2 2026 Earnings Call Transcript

On Wednesday, Kura Oncology (NASDAQ:KURA) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
Benzinga APIs provide real-time access to earnings call transcriptsread more...

Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary

Kura Oncology launches Caspian Therapeutics with $50 million financing to advance menin inhibitor for diabetes and cardiometabolic diseases.read more...

Kura Oncology Names Jennifer Fulk CFO

(RTTNews) - Kura Oncology, Inc. (KURA), on Tuesday appointed Jennifer Fulk as Chief Financial Officer, effective September 8...

KURA Stock Gains 37.6% in a Month: Here's What You Need to Know

Kura's rising Komzifti sales, promising AML data and pipeline catalysts boost investor confidence and fuel KURA's gains.

Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock?

Kura Oncology (KURA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.

 Company News for Aug 26, 2026

Companies in The News Are: DKS,KURA,NVTS,WMT

KURA Stock Hits Fresh 52-Week High As CEO Buys More Shares — Retail Wonders If Wilson Is Following Moderna CEO’s Playbook

Equity

According to a filing with the SEC, Kura President and CEO Troy Edward Wilson bought 100,000 shares of common stock on August 24 for about $1.24 million in total.


Kura Oncology CEO Buys 100,000 Shares for $1.2 Million. Does This Large Buy Bode Well for Shares in 2026?

Key PointsThe President and CEO acquired ~100,000 shares at $12.39 per share for a total transaction value of $1.2 million...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Bearish Sentiment

<ul class="summary-bullets"><li>Over eight days, Wilson has invested around $2.35 million in company stock.</li><li>The buying comes shortly after Kura reported second-quarter results showing early commercial traction for its approved drug KOMZIFTI.</li><li>A retail trader asked whether KURA stock is following the playbook of Moderna CEO Stéphane Bancel, who bought shares in March at a significant discount to the current price.</li></ul><p>Shares of Kura Oncology (KURA) closed 10% higher on Tuesday after hitting a fresh 52-week high above $13.90, as investors reacted to the company’s CEO buying more shares of the company.</p><p>The stock clocked its best day on Tuesday since May.</p><h2 class="st-heading-2">CEO Adds To Stake In Open-Market Buys</h2><p>According to an SEC filing, Kura President and CEO Troy Edward Wilson bought 100,000 shares of common stock on August 24. The shares were acquired in multiple trades at prices ranging from $11.47 to $12.85, for a weighted average of $12.39—about $1.24 million in total. The shares are held through a trust.</p><p>This follows a similar purchase of an additional 100,000 shares on August 17 at a weighted-average price of $11.12. Over eight days, Wilson has invested around $2.35 million in company stock, a move widely seen as a vote of confidence.</p><h2 class="st-heading-2">Strong Start For Commercial Product</h2><p>The buying comes shortly after Kura reported second-quarter results showing early commercial traction for its approved drug KOMZIFTI. The therapy generated $9.1 million in net product sales, up 57% from the prior quarter. It has already captured a majority share of new patients in its approved use for certain relapsed or refractory blood cancers.</p><p>The company ended June with $519 million in cash and investments, plus expected partnership payments that will support operations for years to come.</p><h2 class="st-heading-2">Upcoming Data Readouts In Focus</h2><p>In the near term, attention is now on several clinical updates expected in the second half of 2026. These include longer-term results from combination studies of KOMZIFTI with standard treatments in newly diagnosed patients, initial data from pairings with other targeted therapies, and exploratory findings in additional patient groups. Progress on a second candidate, darlifarnib, in solid tumors also continues.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around KURA stock remained ‘bullish’ over the past 24 hours, while message volume was ‘extremely high.’</p><p>A Stocktwits user expressed optimism that the stock would eventually break resistance levels and explode.</p><p><stembedurl>https://stocktwits.com/AdiDasRom/message/662823669</stembedurl></p><p>Another asked whether the Kura CEO is following Moderna CEO’s playbook. Moderna (MRNA) CEO Stéphane Bancel last bought shares of the company on the open market in March for a total value of about $5 million. He bought the shares at a weighted average price of $31.22, and MRNA shares are currently trading at about $159.</p><p><stembedurl>https://stocktwits.com/Jtlo/message/662808425</stembedurl></p><p>A third user applauded the CEO for defending KURA’s stock price.</p><p><stembedurl>https://stocktwits.com/DCZ/message/662797244</stembedurl></p><p><a href="https://stocktwits.com/symbol/KURA">KURA stock</a> has gained 31% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-s-cybertruck-base-version-hits-74-990-nearly-2-x-its-2019-promised-price/cZYkCspRJoL">Tesla’s Cybertruck Base Version Hits $74,990 — Nearly 2X Its 2019 Promised Price</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the logo of Kura Oncology is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

According to a filing with the SEC, Kura President and CEO Troy Edward Wilson bought 100,000 shares of common stock on August 24 for about $1.24 million in total.

Vanguard Total Stock Market ETF

SPDR S&P Biotech ETF

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$9.36
Prev Close	$9.08
Open	$9.17
Dividend Yield	0.00%
50-Day Moving Average	$11.32
Beta	1.18
Avg. Volume	1.81M
PE Ratio	-2.78

52-Week High	$13.90
52-Week Low	$7.36
Market Capitalization	$807.76M
EPS (Annual)	-$3.18
Price to Book	17.19
Revenue Per Employee	$259,546.15

Feed

News

Sentiment

Earnings

Fundamentals

Info

KURA Fundamentals